secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001104659-25-066986
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood dismisses EY as auditor; appoints KPMG; prior adverse ICFR opinion cited
--------------------------------------------------------------------------------

- Dismissed Ernst & Young as independent auditor on July 3, 2025; no disagreements during fiscal 2023 and 2024.
- EY's report on internal controls for fiscal 2024 contained adverse opinion due to material weaknesses in entity-level and ITGC controls.
- Material weaknesses also impacted financial close process and expenditure controls; no restatement required.
- Audit Committee appointed KPMG as new independent auditor effective immediately for FY 2025.
- EY agreed with disclosures; furnished letter to SEC dated July 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925066986/0001104659-25-066986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925066986/tm2520217d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-066986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer